Radiologix reports mixed results for 2Q

Article

Imaging services provider Radiologix reported a net loss of $2.1 million, or 10¢ per diluted share, compared with net income of $276,000, or 2¢ per diluted share for the same period last year. Income from continuing operations excluding charges and a

Imaging services provider Radiologix reported a net loss of $2.1 million, or 10¢ per diluted share, compared with net income of $276,000, or 2¢ per diluted share for the same period last year. Income from continuing operations excluding charges and a gain on sale of operations rose, however, to $1 million, or 5¢ per diluted share, compared with $898,000, or 4¢ per diluted share in 2Q 2003. Earnings before interest, taxes, depreciation, and amortization (EBITDA) were $12.5 million for 2Q 2004, compared with $12.6 million for 2Q 2003. Adjusted EBITDA as a percentage of service fee revenue was 18.4% for the 2Q 2004, compared with 20.3% for 2Q 2003.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.